Heilongjiang ZBD Pharmaceutical Co., Ltd.
Status: Publicly traded
Direct answer
Heilongjiang ZBD Pharmaceutical Co., Ltd. is publicly traded on SHH under the ticker 603567.SS.
Heilongjiang ZBD Pharmaceutical Co., Ltd. is a Chinese pharmaceutical firm dedicated to the entire lifecycle of Traditional Chinese Medicine (TCM), from research and development to manufacturing and sales, exclusively within China. Its extensive product portfolio addresses a wide spectrum of health concerns, including conditions related to cardiovascular and cerebrovascular health, respiratory ailments, orthopedic...
Can you invest in Heilongjiang ZBD Pharmaceutical Co., Ltd.?
Yes. Heilongjiang ZBD Pharmaceutical Co., Ltd. trades publicly on SHH as 603567.SS.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Heilongjiang ZBD Pharmaceutical Co., Ltd.
Detailed equity research is provided by MarketSnap.